Latest research report on “Glucagon Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5560336
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
This report contains market size and forecasts of Glucagon in global, including the following market information:
Global Glucagon Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glucagon Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Glucagon companies in 2021 (%)
The global Glucagon market was valued at 572.1 million in 2021 and is projected to reach US$ 851 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inject Glucagon Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glucagon include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucagon manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucagon Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Glucagon Market Segment Percentages, by Type, 2021 (%)
– Inject Glucagon
– Nasal Glucagon
Global Glucagon Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Glucagon Market Segment Percentages, by Application, 2021 (%)
– Emergency Kits
– General Use
– Diagnostic & Motility
– Cardiogenic Shock
Global Glucagon Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Glucagon Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Glucagon revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glucagon revenues share in global market, 2021 (%)
Key companies Glucagon sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Glucagon sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Novo Nordisk
– Eli Lilly
– Fresenius Kabi
– Torrent Labs
– Taj Pharmaceuticals
– Xeris Pharmaceuticals
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5560336
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441